Business
CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City
REHOVOT, Israel, April 23, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company will present at the
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"REHOVOT, Israel, April 23, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 10:00 am ET in the Lotus East room of the Mandarin Oriental Hotel in New York City. \nThe ThinkEquity Conference brings together companies in the technology, healthcare, finance, and energy industries with institutional and accredited investors. ThinkEquity is a division of Fordham Financial Management, Inc.\n\"We look forward to presenting to the New York investment community our key activities and latest developments at CollPlant, including medical aesthetics and the collaboration with United Therapeutics for 3D Bioprinting of solid organs for human transplant,\" stated CollPlant CEO, Yehiel Tal.\nAbout CollPlant\nCollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs, medical aesthetics, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. Our products are based on our rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology.\nOur products address indications for the diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. Our flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. We recently entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans. CollPlant's unique Vergenix line of rhCollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds.\nFor more information about CollPlant, visit http://www.collplant.com\nSafe Harbor Statements\nThis press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to CollPlant's objectives plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that CollPlant intends, expects, projects, believes or anticipates will or may occur in the future. These statements are of...